Nanotherapeutics Gets FDA Orphan-Drug Status for NanoDTPA™ Capsules to Treat Radiation Exposure
Nanotherapeutics, Inc. announced today that NanoDTPA™ capsule, the company’s new oral product under development for treatment of known or suspected cases of internal contamination from exposure to radioactive plutonium, am...
Japanese officials say conditions at the Fukushima Dai-ichi nuclear power plant have markedly improved since the March 11 disaster, but the plant still won't be completely stabilized until early next year. At a meeting of...
